BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,838,388 | +14.9% | 62,300 | +2.3% | 0.07% | +12.5% |
| Q1 2023 | $2,470,104 | +135993.9% | 60,900 | +71.1% | 0.06% | +16.4% |
| Q4 2022 | $1,815 | -99.9% | 35,600 | +12.3% | 0.06% | -1.8% |
| Q3 2022 | $1,707,000 | +114.4% | 31,700 | +155.6% | 0.06% | +143.5% |
| Q2 2022 | $796,000 | -90.0% | 12,400 | -86.6% | 0.02% | -85.8% |
| Q4 2021 | $7,966,000 | -9.1% | 92,800 | -14.8% | 0.16% | -10.0% |
| Q3 2021 | $8,759,000 | -4.8% | 108,900 | -4.7% | 0.18% | -4.3% |
| Q2 2021 | $9,201,000 | +10.5% | 114,300 | +15.8% | 0.19% | +2.7% |
| Q1 2021 | $8,324,000 | +2.9% | 98,700 | -2.1% | 0.18% | +2.8% |
| Q4 2020 | $8,088,000 | +107.0% | 100,800 | +107.4% | 0.18% | +67.9% |
| Q3 2020 | $3,908,000 | -45.4% | 48,600 | -41.5% | 0.11% | -49.0% |
| Q2 2020 | $7,155,000 | +20.7% | 83,100 | +13.8% | 0.21% | -3.7% |
| Q1 2020 | $5,927,000 | +2.4% | 73,000 | +5.5% | 0.22% | +30.1% |
| Q4 2019 | $5,787,000 | -18.3% | 69,200 | -14.6% | 0.17% | -21.3% |
| Q3 2019 | $7,085,000 | +6.8% | 81,000 | 0.0% | 0.21% | +10.5% |
| Q2 2019 | $6,634,000 | -7.1% | 81,000 | -7.7% | 0.19% | -8.2% |
| Q1 2019 | $7,139,000 | -22.5% | 87,800 | -26.5% | 0.21% | -12.6% |
| Q3 2018 | $9,212,000 | +40.8% | 119,500 | +34.9% | 0.24% | +34.5% |
| Q2 2018 | $6,542,000 | +5.2% | 88,600 | -7.3% | 0.18% | +9.9% |
| Q1 2018 | $6,218,000 | -60.6% | 95,600 | -60.8% | 0.16% | -55.0% |
| Q4 2017 | $15,780,000 | -7.6% | 244,126 | -10.3% | 0.36% | -10.5% |
| Q3 2017 | $17,081,000 | -3.4% | 272,200 | -6.8% | 0.40% | -8.7% |
| Q2 2017 | $17,690,000 | +5.3% | 292,200 | -9.8% | 0.44% | +11.2% |
| Q1 2017 | $16,797,000 | +18.2% | 323,900 | +1.0% | 0.39% | +1.3% |
| Q4 2016 | $14,215,000 | +2.1% | 320,600 | +9.6% | 0.39% | +4.3% |
| Q3 2016 | $13,928,000 | +10.4% | 292,600 | +4.8% | 0.37% | +15.8% |
| Q2 2016 | $12,621,000 | +13.1% | 279,100 | +2.7% | 0.32% | +10.3% |
| Q1 2016 | $11,161,000 | +10.5% | 271,700 | +2.6% | 0.29% | +1.0% |
| Q4 2015 | $10,102,000 | +72.7% | 264,800 | +48.7% | 0.29% | +69.0% |
| Q3 2015 | $5,851,000 | -61.1% | 178,100 | -17.2% | 0.17% | -60.7% |
| Q2 2015 | $15,049,000 | +165.3% | 215,200 | +159.9% | 0.44% | +170.2% |
| Q1 2015 | $5,672,000 | -17.4% | 82,800 | -11.6% | 0.16% | +1.3% |
| Q4 2014 | $6,867,000 | +60.0% | 93,700 | +56.7% | 0.16% | +57.4% |
| Q3 2014 | $4,292,000 | -2.5% | 59,800 | -1.8% | 0.10% | +4.1% |
| Q2 2014 | $4,403,000 | -38.6% | 60,900 | -37.5% | 0.10% | -41.2% |
| Q1 2014 | $7,174,000 | -10.1% | 97,500 | -15.0% | 0.16% | -12.2% |
| Q4 2013 | $7,977,000 | -1.0% | 114,700 | -6.5% | 0.19% | -8.7% |
| Q3 2013 | $8,060,000 | -19.7% | 122,700 | -15.3% | 0.21% | -21.1% |
| Q2 2013 | $10,037,000 | – | 144,900 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |